piCHEM exhibited from 25 to 27 Octobre 2011 at the CPhI/ICSE Worldwide, Frankfurt.

Thank you for your visits and interesting talkings about your project ideas. It was a very good opportunity for piCHEM again to  present our products and services.

We are looking forward to see you next year in Madrid!

Our website is presented now in 3 languages. piCHEM informs you in English, Portuguese and Espanol!

Please select your preferred language above.

InnaVirVax and piCHEM agree cooperation on the development of a synthetic therapeutic vaccine candidate for HIV-infection.

InnaVirVax SA (www.innavirvax.fr), a privately-owned biopharmaceutical company located in the Paris Region biopark of Evry, France is dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognosis of AIDS and HIV infection and new cancer therapies.

piCHEM provides its extensive know-how in the development and production of peptide based active pharmaceutical ingredients for the development of new and innovative drugs.

The agreed cooperation is another important step for piCHEM to broaden its competency in the development and production of vaccines.

piCHEM is very proud to be involved in the fight against HIV/AIDS!

piCHEM participa na CPhI/ ICSE 2009 em Madrid (13-15 de Outubro).